Bivigam®

Understanding Bivigam® 

Bivigam® (human interferon gamma-1b) is an intravenous immunoglobulin (IVIG) therapy used to prevent serious infections in patients with chronic granulomatous disease (CGD), a rare inherited immune disorder. CGD impairs the body’s ability to fight certain bacterial and fungal infections, making patients highly susceptible to recurrent and severe infections.

How Bivigam® Works:

• Prevents serious bacterial and fungal infections in CGD patients.
• Provides essential antibodies to strengthen immune response.
• Supports long-term infection control and improves quality of life.

FDA Approval:

• 2012 – Approved for the treatment of chronic granulomatous disease (CGD)

For more information, please visit the Bivigam® patient website and speak with your healthcare provider to determine if Bivigam® is the right treatment option for you.